Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. - Wikidata - wikimedia - TriplyDB

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

http://www.wikidata.org/entity/Q34877439

about

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Estimates of young breast cancer survivors at risk for infertility in the U.S.Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/00 Tamoxifen and ovarian function.Fertility preservation in female cancer patients: An overview.Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progre Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.Fertility counseling of young breast cancer patients.Hormonal therapies in young breast cancer patients: when, what and for how long?Prediction of ovarian function in premenopausal breast cancer patients with amenorrhoea after chemotherapy: a simple clinical score Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.Oncofertility in Canada: gonadal protection and fertility-sparing strategies.Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial.Genetic variants in microRNAs and breast cancer risk in African American and European American women.Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane.Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis.

P2860

Q26773986-B933C0BC-E82E-4503-A184-0FD10695A7E2 Q26853619-EF8C11D3-EE8E-472C-958A-BB9FB03BBA77 Q28240178-27EC8B40-D320-4D06-A3B5-2C0986C826EC Q33838766-FB7D13E1-E3AD-48F9-AB22-57E0A3EBB9FB Q34005150-D2CC9D94-B17A-4FA9-AB22-1E687C0B2D2C Q34199348-96F618F9-060E-4B29-B1D2-DD9FCB409288 Q34805784-BD4DF6D2-8337-4F9E-B184-80131ADFF2AF Q35237851-1B0937C6-1A0E-40B3-B60A-F1D5DFDD7240 Q35789448-5697B5A0-46BA-4B3F-89C2-CC3A0E7E3DE1 Q36022957-C25E3520-022F-4E78-8893-C881B3292F83 Q36116355-37FC8C63-EE1A-483B-B627-A8131804ED16 Q36251684-E8B762FB-B380-4504-8B0B-5747E2D5C300 Q36404774-01B0F25B-BFAB-46F2-B188-1EBD4D3E21CD Q36490058-8BC4806E-22A5-4794-89F8-6AF19DE07447 Q36713321-5C1E0B47-0736-4822-B498-15465D902271 Q36963384-195DB113-5919-4F90-A7C3-5D0919A380B2 Q36963393-602224B6-FBD2-4F6C-AB21-B6D1408A9DE7 Q37083638-C270F995-4EB8-4731-906E-2452C1312FB1 Q37213101-905F5C73-FFC6-4A86-854D-41D3BABE8C5A Q37281010-7830896E-0FF1-4E5C-BA74-22CB33233D28 Q37284872-91A4E19B-FEF0-4BB2-B07E-5EC2D6A7B6FE Q37364626-EA67D0C1-3B88-4526-B2B6-E6D20C1A2F08 Q37376419-4E3F1886-3810-4201-9151-DA59352DEAD2 Q37376778-055423ED-9039-41B0-A4F9-71DBF78D27AD Q38374932-492A0AC3-1C29-4405-8369-968719918CC5 Q43727879-B6F23F48-1E79-4FC2-A097-C9046FFF21C2 Q44437527-11817D4B-A8C8-47FA-85E1-C72BBCAE757D Q46606896-BA826B2C-964B-4FF2-994E-D15E6B76F9C6 Q48306515-62F91F6B-9AA6-4CA7-BDB6-52D2C0FA6703

P2860

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

http://www.wikidata.org/entity/Q34877439

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@ast

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@en

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@nl

type

label

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@ast

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@en

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@nl

prefLabel

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@ast

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@en

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@nl

P1433

Q34877439-9A4F5CA2-2C7E-4A5A-95F3-C77D70B7CEB0

P1476

Q34877439-84142C05-416C-4207-B354-441A7FF60998

P2093

Q34877439-17D6B6E9-357E-484A-A434-AA2292CBA238

Q34877439-233DA948-C7B0-4883-80C8-B7D36619390C

Q34877439-31E9720C-3D93-4CF0-B624-B74E855263A6

Q34877439-50438636-661D-40CE-889F-A1B4D3BA1A24

Q34877439-658C567E-B03A-47A9-A503-2E1E12B95267

Q34877439-788AE737-6F50-4316-8FE6-1683F4991567

Q34877439-7A56CF4E-3481-4CAE-AF5A-B1B23BF3245B

Q34877439-7D1307DA-8908-4DCE-851D-8891196F3915

Q34877439-8F509EBE-000E-4FDA-8B39-104FA64044D4

Q34877439-B0D4BF52-EA66-4A1E-AD06-ECCA5E8A80A4

P2860

Q34877439-02FD7073-78CD-4339-A546-EE82655CE593

Q34877439-0460559D-1A89-4A50-AAB4-B5970D731DFE

Q34877439-22694736-FB4E-44F9-A790-2F53F1BF5691

Q34877439-2672C7BC-ED72-4ED8-AE4E-8FD713476223

Q34877439-3B2AD06F-D2B7-4D29-96E0-24DBB1211475

Q34877439-42BDD53C-AE7C-43AE-ABAD-8B64003B8735

Q34877439-4F468BEC-F558-416E-801E-B218364750D4

Q34877439-4F4BAE7A-B62C-415D-9BF9-761C7AD2B1F1

Q34877439-5EAABE7B-5D73-48BC-81A2-11ADD4D2FA9A

Q34877439-67DC35A3-C14E-4909-934E-5136A2B66B95

P304

Q34877439-4EF0576C-B01C-409C-946D-7E908BB24238

P31

Q34877439-BED6D5F9-C8E3-4CCF-B86F-63C90C6261CE

P356

Q34877439-A183D0A9-C5F4-427E-82E3-3922F4E151D0

P407

Q34877439-2EF5A2F8-5121-42F1-B8C6-8340F85D410C

P433

Q34877439-EFE0DE0B-C10C-49E0-ADD2-85BA4CF56C2F

P478

Q34877439-0EFEA9DF-69D3-4EC5-9A4A-3D69CB1161EA

P50

Q34877439-0D1D8351-9E47-4175-A4A4-B5BD1A0A51D3

Q34877439-D4E2237C-25F0-4D96-9C38-55F7740B367C

P577

Q34877439-68A45962-430E-4686-A1F4-3ACF018D3F11

P5875

Q34877439-B0C6D96F-D163-4F99-996A-FBC847045C9A

P698

Q34877439-3AC468C3-53DF-4626-81B9-4A671C9E6E84

P921

Q34877439-2C9D12F6-1EA8-4DE8-8B42-8E4F45024783

Q34877439-92270188-1D3A-42C9-9667-2C5E8B895A9D

P932

Q34877439-95E76874-75D6-4301-8F99-A14B2540A2C4

P356

JCO.2010.29.7689

P1433

Journal of Clinical Oncology

P1476

Menstrual history and quality- ...... erapy on the NSABP B-30 trial.

@en

P2093

Charles E Geyer

http://www.w3.org/2001/XMLSchema#string

Edith A Perez

http://www.w3.org/2001/XMLSchema#string

Eduardo R Pajon

http://www.w3.org/2001/XMLSchema#string

Eleftherios P Mamounas

http://www.w3.org/2001/XMLSchema#string

James N Atkins

http://www.w3.org/2001/XMLSchema#string

John K Erban

http://www.w3.org/2001/XMLSchema#string

Jonathan A Polikoff

http://www.w3.org/2001/XMLSchema#string

Joseph P Costantino

http://www.w3.org/2001/XMLSchema#string

Louis Fehrenbacher

http://www.w3.org/2001/XMLSchema#string

Norman Wolmark

http://www.w3.org/2001/XMLSchema#string

P2860

Preservation of fertility in patients with cancer.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Menopause and breast cancer: symptoms, late effects, and their management.

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.

P304

1110-1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.29.7689

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Sandra M. Swain

P577

2011-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49817130

http://www.w3.org/2001/XMLSchema#string

P698

21300930

http://www.w3.org/2001/XMLSchema#string

P921

Amzerioù (merc'hed)

quality of life

P932

3083866

http://www.w3.org/2001/XMLSchema#string